Cancer drugs approved in the US by the FDA have an average of 6.5 years to go from the first clinical trial in adults to the first trial in children, according to a study at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. The study was published in the May issue of the European Journal of
A new study conducted by researchers from the University of Southern California in Los Angeles, explains how aerobic and resistance exercise can increase life expectancy for patients who have successfully completed breast cancer treatment. According to National Cancer Institute estimates, in 2017 there were approximately 252,710 new diagnoses of breast cancer in the United States.
The US biotech announces that it has licensed a late-stage stroke drug that could be the first treatment advancement in the therapy area since the 1990s. Biogen will pay Remedy Pharmaceuticals $120 million for Cirara, which is currently heading towards Phase III trials in ischaemic stroke. If Ciara makes it to the market, it could
